Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-024149)

Filing Details

Accession Number:: 0000950170-25-024149
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-20 16:10:03
Reporting Period:: 2025-02-18

Filing Date:: 2025-02-20
Accepted Time:: 2025-02-20 16:10:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1745999	Beam Therapeutics Inc.	BEAM	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2033155	J Bethany Cavanagh	C/O Beam Therapeutics Inc., 238 Main Street Cambridge MA 02142	Svp, Finance And Treasurer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-02-18	6,287	$35.00	37,527	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2024.